PROVIDER PROFILE · NPI 1164861167
Jad ChahoudM.D.
PRESCRIBING · PART D · 2024
Total Rx claims
198
Beneficiaries
—
Total drug cost
$3.6M
Distinct drugs
7
Brand share
60.1%
Top prescribed drugs
Everolimus45 claims
Cabozantinib S-Malate42 claims
Axitinib35 claims
Lenvatinib Mesylate31 claims
Prednisone20 claims
QUALITY · MIPS · 2024
Final MIPS score
88.0
Quality
74.0
Cost
71.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.55%
Group
CROSS-REFERENCE